Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Traws Pharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 32 | +5 |
| Shares | 1.95M | 72.2K | 1.79M | −95.3K (−5.1%) |
| Value | $3.60M | $133.0K | $2.36M | −$1.10M (−31.9%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Traws Pharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 59,512 | $79.0K | 0.00% |
| Jane Street Group, LLC | 14,977 | $20.0K | 0.00% |
| StoneX Group Inc. | 15,000 | $19.8K | 0.00% |
| Susquehanna International Group, LLP | 13,356 | $18.0K | 0.00% |
| Citigroup Inc | 135 | $0 | 0.00% |
| Northwestern Mutual Wealth Management Co | 33 | $0 | 0.00% |
| Cordasco Financial Network | 132 | $0 | 0.00% |
| Glassman Wealth Services | 133 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 10 | $0 | 0.00% |
| Evoke Wealth, LLC | 4 | $0 | 0.00% |
Sold out (5)
Institutions that held Traws Pharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Two Sigma Investments, LP | 63,627 | $117.0K |
| Dimensional Fund Advisors LP | 22,348 | $41.0K |
| Ikarian Capital, LLC | 18,975 | $35.0K |
| JPMorgan Chase & Co | 4,813 | $9.00K |
| Tower Research Capital LLC (TRC) | 1,479 | $3.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Traws Pharma, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 72,167 | $133.0K |